Sensitivity Analyis: Risk Ratios for viral suppression following different adjustment schema for missing data.

<p>Sensitivity Analyis: Risk Ratios for viral suppression following different adjustment schema for missing data.</p

Antiretroviral treatment by trial participation.

<p>Antiretroviral treatment by trial participation.</p

Baseline sample characteristics for study population, complete cases and comparing trial to non-trial participants restricted to complete cases.

*<p>p value comparing trial to non trial participants restricted to complete cases.</p>1<p>MSM = Men who have sex with Men;</p>2<p>Non Black includes Caucasian, Hispanic and Other race.</p>3<p>Public insurance =  Medicaid/Medicare;</p>4<p>ID =  University of North Carolina Infectious Disease.</p>5<p>HAART Category; NRTI – Nucleoside Reverse Transcriptase Inhibitor; PI/r – Protease Inhibitor/Ritonavir; NNRTI - Non Nucleoside Reverse Transcriptase Inhibitor.</p>6<p>ANC = Absolute Neutrophil Count.</p>7<p>ALT = Alanine amino transferase.</p

Risk Ratios for virologic suppression by trial participation within strata of HAART period.

<p>**adjusted for age, distance traveled to receive care at UNC ID clinic, baseline HIV RNA levels, CD4 cell count, months from HIV diagnosis to HAART initiation, creatinine, type of HAART.</p